INS and Hypoglycemia: HH is characterised by hypoglycaemia with an inadequate suppression of insulin, detectable C-peptide, a suppressed or low level of ketones (3-β-hydroxybutyrate < 2 mmol/L) and an absence of metabolic acidosis [20].